Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery

Qimanguli Saiding,Zhongyang Zhang,Shuying Chen,Fan Xiao,Yumeng Chen,Yongjiang Li,Xueyan Zhen,Muhammad Muzamil Khan,Wei Chen,Seyoung Koo,Na Kong,Wei Tao

DOI: https://doi.org/10.1016/j.addr.2023.115116

IF: 16.1

2023-10-22

Advanced Drug Delivery Reviews

Abstract:Upon entering the biological milieu, nanomedicines swiftly interact with the surrounding tissue fluid, subsequently being enveloped by a dynamic interplay of biomacromolecules, such as carbohydrates, nucleic acids, and cellular metabolites, but with predominant serum proteins within the biological corona. A notable consequence of the protein corona phenomenon is the unintentional loss of targeting ligands initially designed to direct nanomedicines toward particular cells or organs within the in vivo environment. Traditional nanomedicines often focus on encapsulating drugs or therapeutic agents within nanoparticles to enhance their stability, solubility, and extension of circulation time; nevertheless, mRNA nanomedicine displays extra high demand for specific cell and tissue-targeted delivery to effectively transport mRNA molecules into target cells, where they can exert their therapeutic effects with utmost efficacy. In this review, focusing on the delivery systems and tissue-specific applications, we aim to update the nanomedicine population with the prevailing and still enigmatic paradigm of nano-bio interactions, a formidable hurdle in the pursuit of targeted mRNA delivery. We also elucidate the current impediments faced in mRNA therapeutics and, by contemplating prospective avenues—either to modulate the corona or to adopt an 'ally from adversary' approach—aim to chart a course for advancing mRNA nanomedicine.

pharmacology & pharmacy